Quironsalud Madrid
Testicular cancer treatment cost in Spain typically starts with essential diagnostics like a PET/CT scan ranging from $1,300 to $1,800. Primary surgical interventions, such as an orchiectomy, cost between $3,500 and $6,500, while specialized radiation therapy for testicular cancer runs from $4,100 to $9,400. Final expenses depend on the clinical stage, prosthesis requirements, and chosen facility tier. Patients often save 30-50% compared to US private healthcare costs. Top treatment centers are located in Madrid, Barcelona, and Pamplona.
Typical Testicular Cancer Treatment Costs in Spain
Bookimed Expert Insight: Patients seeking high-precision surgical outcomes should prioritize JCI-accredited centers like Hospital Quiron Barcelona. Dr. Antonio Alcaraz at Quiron Barcelona is a global pioneer with over 500 successful urogenital operations using robotic systems. For complex cases requiring clinical trials or advanced research, Quironsalud Madrid offers unique access to experimental protocols. Clinica Universidad de Navarra reflects premium care with 5-star ratings and specialized onco-hematology expertise. GenesisCare provides targeted options for those requiring specialized radiotherapy technologies like CyberKnife.
| Turkey | Austria | Spain | |
| Testicular prosthesis | from $1,500 | from $3,500 | from $2,100 |
| Removal of testicle tumor | from $4,500 | from $8,500 | from $8,000 |
| Radiation therapy for testicular cancer | from $4,800 | from $7,037 | from $4,103 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Orchiectomy | from $2,889 | from $9,000 | from $3,500 |
38 years of experience specializing in urologic oncology – Dr. Alcaraz has performed 500+ surgeries for urogenital cancers, including minimally invasive techniques.
Dr. Joseba Rebollo Liceaga brings over 36 years of experience of oncology experience, specializing in testicular cancer at Quironsalud Torrevieja.
140+ published articles on urological cancers – Dr. Mellado Gonzalez leads translational research at Hospital Clínic de Barcelona's IDIBAPS institute.
The doctor is a distinguished medical oncologist with over 30 years of experience, specializing in the non-surgical treatment of genitourinary cancers, including prostate, kidney, and bladder cancers, as well as sarcomas and tumors of unknown origin. Currently, the doctor leads the Genitourinary, Central Nervous System, Sarcoma, and Unknown Origin Tumors Unit at Vall d'Hebron University Hospital in Barcelona and is affiliated with the Teknon Medical Center.
With a Ph.D. in Medicine and Surgery, the doctor has led numerous national multicenter clinical trials and has authored over 120 peer-reviewed articles. The doctor is recognized as one of Spain's leading experts in genitourinary oncology.
Written by Anna Leonova